Back to search

Article

Nf-κβ Inhibitor – Dehydroxymethylepoxyquinomicin Reduces Iron Iso-Maltoside Toxicity Towards Peritoneal Mesothelial Cells

2023-06-09

Abstract excerpt

<h4>Background: </h4> Intravenous iron therapy is used in treatment of anemia in uremic pa-tients. In patients treated with peritoneal dialysis iv. infused iron diffuses into the peritoneal cavity and may cause injury to the mesothelial cell. Methods. We studied effect of Iron Isomaltoside (IIS) in presence of NF-κβ inhibitor dehydroxymethyepoxyquinmicin (DHMEQ) on function of the peritoneal mesothelial cells. Exp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e7a56292-dd0d-5c43-8a1e-1907f8241b50
DOI
10.20944/preprints202306.0701.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Select a neighboring publication to make it the new centre.